Epilepsy Foundation of America Welcomes Accomplished Communications Executive to National Board of Directors

BOWIE, Md., July 10, 2025 (GLOBE NEWSWIRE) — The Epilepsy Foundation of America (EFA) is proud to announce the appointment of Daryl Drabinsky, distinguished communications and corporate affairs executive, to its National Board of Directors. Drabinsky brings extensive leadership experience in digital innovation, reputation management, and brand transformation across healthcare, technology, and global business sectors […]

Epilepsy Foundation of America Welcomes Accomplished Communications Executive to National Board of Directors

Epilepsy Foundation of America Welcomes Accomplished Communications Executive to National Board of Directors GlobeNewswire July 10, 2025 BOWIE, Md., July 10, 2025 (GLOBE NEWSWIRE) — The Epilepsy Foundation of America (EFA) is proud to announce the appointment of Daryl Drabinsky, distinguished communications and corporate affairs executive, to its National Board of Directors. Drabinsky brings extensive

AVALINE AND STELLA MCCARTNEY TOAST TO SUMMER WITH A LIMITED-EDITION ROSÉ BOTTLE

A stylish collaboration rooted in summer celebration This summer, Avaline, the organic wine brand founded by Cameron Diaz and Katherine Power, unveils its most stylish pour yet: a limited-edition bottle of its beloved French Rosé, dressed in a custom design by iconic fashion designer and sustainability advocate Stella McCartney. Together, they've created a statement piece

Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock

(NASDAQ:SLNO), REDWOOD CITY, Calif., July 10, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (Nasdaq: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that it has priced its previously announced underwritten public offering of 2,352,941 shares of its common stock at a price to the public of $85.00

Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock

Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock GlobeNewswire July 10, 2025 REDWOOD CITY, Calif., July 10, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (Nasdaq: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that it has priced its previously announced underwritten public offering

Scripps to release second-quarter 2025 operating results on Aug. 7

The E.W. Scripps Company (NASDAQ: SSP) will report second-quarter 2025 operating resultsafter the markets close on Thursday, Aug. 7. The call with the company's senior management team will take place at 9 a.m. Eastern time on Friday, Aug. 8. https://mma.prnewswire.com/media/1978175/Scripps_Logo.jpg The company's protocol for joining its earnings calls is as follows: — To access a

Safeture and Riskline Launch Wildfire Safety Guide for Travelers

Wildfires are no longer isolated events. Once seen as regional disasters, they have now become a global issue, significantly affecting travel and creating serious health and safety concerns for millions worldwide. From the Mediterranean to the Americas, fires are increasingly impacting popular travel spots-often without warning. To address this rising threat, Safeture, a leading technology

Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause

(NASDAQ:PGNY), NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced a new partnership with ÅŒURA, maker of the world's leading smart ring, further empowering women to better understand and take action on their health through comprehensive data and personalized insights.

Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause

Progyny Partners with ÅŒURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause GlobeNewswire July 10, 2025 NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced a new partnership with ÅŒURA,

Unbounce Fast-Tracks AI and Feature Innovation to Empower GTM Teams

Unbounce, the leading go-to-market (GTM) software platform for growing small and midmarket brands and agencies, today announced a host of new AI capabilities and feature integrations. https://mma.prnewswire.com/media/2727887/Unbounce_Unbounce_Fast_Tracks_AI_and_Feature_Innovation_to_Empow.jpg These new additions reflect the rapid momentum and strategic alignment between the Unbounce and Insightly teams following their July 2024 merger. The two brands-now part of the Unbounce

Scroll to Top